Beyond Trastuzumab and Lapatinib: New Options for HER2-Positive Breast Cancer

• Date :
• 4    
  0

CancerLinQ and the Future of Cancer Care

• Date :
• 3    
  0

Stem Cell Transplant As an Immunomodulatory Tool for Children with Hematologic Malignancies

• Date :
• 3    
  0

Obesity and Inflammation: New Insights into Breast Cancer Development and Progression

• Date :
• 3    
  0

Antibody-Drug Conjugates in Hematologic Malignancies

• Date :
• 2    
  0

Do Our Current Clinical Trial Designs Help to Guide Clinical Practice ?

• Date :
• 2    
  0

Drug Development: Neoadjuvant Opportunities in Breast Cancer

• Date :
• 2    
  0

Early Integration of Palliative and Supportive Care in the Cancer Continuum: Challenges and Opportunities

• Date :
• 2    
  0

Emerging Molecular-Targeted Therapies in Early-Phase Clinical Trials and Preclinical Models

• Date :
• 2    
  0

Risk Stratification of Rhabdomyosarcoma: A Moving Target

• Date :
• 2    
  0

The Role of JAK1/2 Inhibitors in the Treatment of Chronic Myeloproliferative Neoplasms

• Date :
• 2    
  0

Therapeutic Vaccines and Immunotherapy in Castration-Resistant Prostate Cancer: Current Progress and Clinical Applications

• Date :
• 2    
  0

Thrombosis and Cancer: Emerging Data for the Practicing Oncologist

• Date :
• 2    
  0

Understanding and Surviving the Transition to Value-Based Oncology 2

• Date :
• 2    
  0

Aberrant Epigenetic Regulation: A Central Contributor to Lung Carcinogenesis and a New Therapeutic Target

• Date :
• 1    
  0

Acquired Resistance to Targeted Therapies in Advanced Non-Small Cell Lung Cancer: New Strategies and New Agents

• Date :
• 1    
  0

Adjuvant Chemotherapy in Older Adults with Non-Small Cell Lung Cancer

• Date :
• 1    
  0

An Unappreciated Challenge to Oncology Drug Discovery: Pitfalls in Preclinical Research

• Date :
• 1    
  0

Antiangiogenic Therapy for Glioblastoma: The Challenge of Translating Response Rate into Efficacy 2

• Date :
• 1    
  0

Beyond Trastuzumab and Lapatinib: New Options for HER2-Positive Breast Cancer 2

• Date :
• 1    
  0

Biologic Agents in the Treatment of Colorectal Cancer: The Last Decade; the Lost Decade 3

• Date :
• 1    
  0

Cancer of Unknown Primary Site: Improved Patient Management with Molecular and Immunohistochemical Diagnosis

• Date :
• 1    
  0

CancerLinQ and the Future of Cancer Care 2

• Date :
• 1    
  0

Connecting Molecular Pathways to Hereditary Cancer Risk Syndromes

• Date :
• 1    
  0

Connecting Molecular Pathways to Hereditary Cancer Risk Syndromes 2

• Date :
• 1    
  0

Developments in the Use of Antibody-Drug Conjugates

• Date :
• 1    
  0

Do We Need to Irradiate All Small Invasive Breast Cancers and DCIS ?

• Date :
• 1    
  0

Early and Late Long-Term Effects of Adjuvant Chemotherapy

• Date :
• 1    
  0

Evidence-Based Clinical Practice Guidelines on the Use of Sentinel Lymph Node Biopsy in Melanoma 2

• Date :
• 1    
  0

Familial Gastric and Pancreatic Cancers: Diagnosis and Screening

• Date :
• 1    
  0

Green Tea Polyphenols and Cancer Chemoprevention of Genitourinary Cancer

• Date :
• 1    
  0

Individualizing Treatment Decisions for Older Adults with Hematologic Malignancies 3

• Date :
• 1    
  0

Individualizing Treatment Decisions for Older Adults with Hematologic Malignancies 4

• Date :
• 1    
  0

Locally Advanced Head and Neck Cancer

• Date :
• 1    
  0

Lung Cancer in Developing Countries: Access to Molecular Testing

• Date :
• 1    
  0

Marine-Derived Omega-3 Fatty Acids: Fishing for Clues for Cancer Prevention

• Date :
• 1    
  0

Mechanisms of Resistance to RAF Inhibition in Melanomas Harboring a BRAF Mutation

• Date :
• 1    
  0

Molecular Pathways in Head and Neck Cancer: EGFR, PI3K, and More 2

• Date :
• 1    
  0

Monoclonal Antibody-Based Therapies in the Treatment of Acute Lymphoblastic Leukemia

• Date :
• 1    
  0

National Cancer Plans: The French Experience

• Date :
• 1    
  0

National Plan for Prevention, Early Detection, and Cancer Control in Peru

• Date :
• 1    
  0

New Tools for Diagnosis and Monitoring of Multiple Myeloma

• Date :
• 1    
  0

Nonhormone Therapy for Metastatic Castration-Resistant Prostate Cancer: Chemotherapy, Bone-Targeted Treatments, and Others

• Date :
• 1    
  0

Novel Approaches to Treatment of Double-Refractory Multiple Myeloma

• Date :
• 1    
  0

Myelodysplastic Syndromes: Recent Advancements in Risk Stratification and Unmet Therapeutic Challenges 2

• Date :
• 1    
  0

Obesity and Its Impact on Breast Cancer: Tumor Incidence, Recurrence, Survival, and Possible Interventions

• Date :
• 1    
  0

Obesity and Its Impact on Breast Cancer: Tumor Incidence, Recurrence, Survival, and Possible Interventions 2

• Date :
• 1    
  0

PI3K Pathway in Gynecologic Malignancies

• Date :
• 1    
  0

Perspectives on Electronic Prescribing and Terminologies

• Date :
• 1    
  0

Picking the Optimal Target for Antibody-Drug Conjugates

• Date :
• 1    
  0

Professionalism in Global, Personalized Cancer Care: Restoring Authenticity and Integrity

• Date :
• 1    
  0

Salivary Gland Cancer: An Update on Present and Emerging Therapies 3

• Date :
• 1    
  0

Selecting the Best Drugs for Phase I Clinical Development and Beyond

• Date :
• 1    
  0

Sequencing Systemic Therapies in Advanced RCC: Is There a Best Strategy

• Date :
• 1    
  0

Soy Isoflavones and Breast Cancer

• Date :
• 1    
  0

Stories We Tell One Another: Narrative Reflection and the Art of Oncology

• Date :
• 1    
  0

Surgical Approaches to Invasive Adenocarcinoma of the Gastroesophageal Junction

• Date :
• 1    
  0

Targeting Molecular Aberrations in Urothelial Carcinoma: Are We Almost There ?

• Date :
• 1    
  0

Targeting Molecular Aberrations in Urothelial Carcinoma: Are We Almost There ? (2)

• Date :
• 1    
  0

The Effect of Biology in the Treatment of Small Breast Tumors

• Date :
• 1    
  0

The Ethics of Health Information Technology in Oncology: Emerging Isssues from Both Local and Global Perspectives 2

• Date :
• 1    
  0

The Life and Times of Low-Grade Serous Carcinoma of the Ovary

• Date :
• 1    
  0

The NCI Community Oncology Research Program: What Every Clinician Needs to Know 3

• Date :
• 1    
  0

The Past, Present, and Future of Cytotoxic Chemotherapy and Pathway-Directed Targeted Agents for Soft Tissue Sarcoma

• Date :
• 1    
  0

The Past, Present, and Future of Cytotoxic Chemotherapy and Pathway-Directed Targeted Agents for Soft Tissue Sarcoma 2

• Date :
• 1    
  0

The Power of Words: Discussing Decision Making and Prognosis 2

• Date :
• 1    
  0

The Role of Chemotherapy in the Management of Stage IIIA Non-Small Cell Lung Cancer 2

• Date :
• 1    
  0

Translating Genomic Research into Clinical Practice: Promise and Pitfalls

• Date :
• 1    
  0

Treatment and Trials: Ovarian Cancer in Older Women 3

• Date :
• 1    
  0

Understanding and Surviving the Transition to Value-Based Oncology

• Date :
• 1    
  0

Update on the Initial Therapy of Multiple Myeloma

• Date :
• 1    
  0

Updates in the Management of Ovarian Germ Cell Tumors

• Date :
• 1    
  0

Updates in the Management of Ovarian Germ Cell Tumors 2

• Date :
• 1    
  0

Updates in the Management of Ovarian Germ Cell Tumors 3

• Date :
• 1    
  0

Women in Oncology: Progress, Challenges, and Keys to Success

• Date :
• 1    
  0

Biologic Agents in the Treatment of Colorectal Cancer: The Reality of Where We Are and Where We Need to Go

• Date :
• 0    
  0

A Multidisciplinary Approach in Muscle-Invasive Disease: Novel Chemotherapy Combinations and Targets in Chemoradiation

• Date :
• 0    
  0

ASCO's International Programs and How You Can Become Involved

• Date :
• 0    
  0

Achieving Health Equity in Colorectal Cancer: A Call to Action

• Date :
• 0    
  0

Acquired Resistance to Targeted Therapies in Advanced Non-Small Cell Lung Cancer: New Strategies and New Agents 2

• Date :
• 0    
  0

Acquired Resistance to Targeted Therapies in Advanced Non-Small Cell Lung Cancer: New Strategies and New Agents 3

• Date :
• 0    
  0

Androgen Deprivation for Prostate Cancer: When and How, the Good and the Bad 1

• Date :
• 0    
  0

Androgen Deprivation for Prostate Cancer: When and How, the Good and the Bad 2

• Date :
• 0    
  0

Androgen Deprivation for Prostate Cancer: When and How, the Good and the Bad 3

• Date :
• 0    
  0

Antiangiogenic Therapy for Glioblastoma: The Challenge of Translating Response Rate into Efficacy

• Date :
• 0    
  0

Approach to the Older Patient with Stage II/III Colorectal Cancer: Who Should Get Curative-Intent Therapy ?

• Date :
• 0    
  0

Assessing and Improving Quality of Life in Patients with Head and Neck Cancer

• Date :
• 0    
  0

Beyond Trastuzumab and Lapatinib: New Options for HER2-Positive Breast Cancer 3

• Date :
• 0    
  0

Biologic Agents in the Treatment of Colorectal Cancer: The Last Decade; the Lost Decade 2

• Date :
• 0    
  0

Biology and Treatment of Acute Lymphocytic Leukemia in Adolescents and Young Adults

• Date :
• 0    
  0

Biomarkers and Correlative Endpoints for Immunotherapy Trials: What Can We Learn in Lung Cancer from Other Tumor Types

• Date :
• 0    
  0

Bridging Science and Clinical Practice: How to Use Molecular Markers When Caring for a Patient with Brain Cancer

• Date :
• 0    
  0

Cellular Composition of the Tumor Microenvironment

• Date :
• 0    
  0

Cellular Composition of the Tumor Microenvironment 2

• Date :
• 0    
  0

Communication in View of Limited Resources: International Perspective

• Date :
• 0    
  0

Connecting Molecular Pathways to Hereditary Cancer Risk Syndromes 3

• Date :
• 0    
  0

Current State-of-the-Art Therapy for Advanced Squamous Cell Lung Cancer

• Date :
• 0    
  0

Developing Novel Strategies to Target B-Cell Malignancies

• Date :
• 0    
  0

Difficult to Swallow: Issues Affecting Optimal Adherence to Oral Anticancer Agents

• Date :
• 0    
  0

Disparities and Challenges in Adherence to Oral Antineoplastic Agents

• Date :
• 0    
  0

Drug Development: Neoadjuvant Opportunities in Breast Cancer 2

• Date :
• 0    
  0

Early Integration of Palliative and Supportive Care in the Cancer Continuum: Challenges and Opportunities 2

• Date :
• 0    
  0

Efficient and Effective Models for Integrating Advanced Practice Professionals into Oncology Practice

• Date :
• 0    
  0

Endocrine Resistance: What Do We Know

• Date :
• 0    
  0

Europe Does It Better: Molecular Testing across a National Health Care System—The French Example

• Date :
• 0    
  0

Evidence-Based Clinical Practice Guidelines on the Use of Sentinel Lymph Node Biopsy in Melanoma

• Date :
• 0    
  0

Evidence-Based Clinical Practice Guidelines on the Use of Sentinel Lymph Node Biopsy in Melanoma 3

• Date :
• 0    
  0

Exploring Novel Immune-Related Toxicities and Endpoints with Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer

• Date :
• 0    
  0

Genomic Landscape of Squamous Cell Carcinoma of the Lung

• Date :
• 0    
  0

Genomic, Prognostic, and Cell-Signaling Advances in Uveal Melanoma

• Date :
• 0    
  0

Histology and Fusion Status in Rhabdomyosarcoma

• Date :
• 0    
  0

How Do Mechanisms of Hepatocarcinogenesis (HBV, HCV, and NASH) Affect Our Understanding and Approach to HCC ?

• Date :
• 0    
  0

How to Use Molecular Markers When Caring for a Patient with Brain Cancer: 1P/19Q as a Predictive and Prognostic Marker in the Neuro-oncology Clinic

• Date :
• 0    
  0

Individualizing Treatment Decisions for Older Adults with Hematologic Malignancies

• Date :
• 0    
  0

Individualizing Treatment Decisions for Older Adults with Hematologic Malignancies 2

• Date :
• 0    
  0

Limited-Stage Hodgkin Lymphoma: Optimal Chemotherapy and the Role of Radiotherapy

• Date :
• 0    
  0

Locally Advanced Head and Neck Cancer 2

• Date :
• 0    
  0

Locally Advanced Head and Neck Cancer 3

• Date :
• 0    
  0

Lung Cancer in 2013: State of the Art Therapy for Metastatic Disease

• Date :
• 0    
  0

Lung Cancer in 2013: State of the Art Therapy for Metastatic Disease 2

• Date :
• 0    
  0

Lung Cancer in 2013: State of the Art Therapy for Metastatic Disease 3

• Date :
• 0    
  0

Mammographic Density and Risk of Breast Cancer

• Date :
• 0    
  0

Mammographic Density: Intersection of Science, the Law, and Clinical Practice

• Date :
• 0    
  0

Managing Choices for Older Patients with Colon Cancer: Adjuvant Therapy

• Date :
• 0    
  0

Molecular Pathways in Head and Neck Cancer: EGFR, PI3K, and More

• Date :
• 0    
  0

Molecular Pathways in Head and Neck Cancer: EGFR, PI3K, and More 3

• Date :
• 0    
  0

Molecular Profiling and the Reclassification of Cancer: Divide and Conquer

• Date :
• 0    
  0

Molecular Profiling and the Reclassification of Cancer: Divide and Conquer 2

• Date :
• 0    
  0

Monitoring and Managing Minimal Residual Disease in Acute Lymphoblastic Leukemia

• Date :
• 0    
  0

Multidisciplinary Approach to Brain Metastasis from Melanoma: The Emerging Role of Systemic Therapies

• Date :
• 0    
  0

Multidisciplinary Approach to Brain Metastasis from Melanoma: The Emerging Role of Systemic Therapies 2

• Date :
• 0    
  0

Multidisciplinary Approach to Brain Metastasis from Melanoma: The Emerging Role of Systemic Therapies 3

• Date :
• 0    
  0

Myelodysplastic Syndromes: Recent Advancements in Risk Stratification and Unmet Therapeutic Challenges 3

• Date :
• 0    
  0

Novel Therapeutics in Hepatocellular Carcinoma: How Can We Make Progress

• Date :
• 0    
  0

Myelodysplastic Syndromes: Recent Advancements in Risk Stratification and Unmet Therapeutic Challenges

• Date :
• 0    
  0

Obesity and Gynecologic Cancer Etiology and Survival

• Date :
• 0    
  0

Optimizing Clinical Management of Surgical Margins in Breast-Conserving Therapy for Breast Cancer

• Date :
• 0    
  0

Oral Mucositis in Head and Neck Cancer: Risk, Biology, and Management

• Date :
• 0    
  0

Overcoming Resistance in Chronic Myelogenous Leukemia

• Date :
• 0    
  0

Pathologic Diagnosis, Origin, and Natural History of Pseudomyxoma Peritonei

• Date :
• 0    
  0

Peritoneal Mesothelioma: The Site of Origin Matters

• Date :
• 0    
  0

Photons or Protons for Non-Central Nervous System Solid Malignancies in Children: A Historical Perspective and Important Highlights

• Date :
• 0    
  0

Photons or Protons for Non-Central Nervous System Solid Malignancies in Children: A Historical Perspective and Important Highlights 2

• Date :
• 0    
  0

Prostate Cancer Screening in BRCA and Lynch Syndrome Mutation Carriers

• Date :
• 0    
  0

Rare Epithelial Tumors Arising in or near the Ovary: A Review of the Risk Factors, Presentation, and Future Treatment Direction for Ovarian Clear Cell and Mucinous Carcinoma

• Date :
• 0    
  0

Rare but Real: Management of Small Bowel Adenocarcinoma

• Date :
• 0    
  0

Reducing Inequalities in Cancer Outcomes: What Works

• Date :
• 0    
  0

Reducing Inequalities in Cancer Outcomes: What Works 2

• Date :
• 0    
  0

Revisiting the Role of Radiation Treatment for Non-serous Subtypes of Epithelial Ovarian Cancer

• Date :
• 0    
  0

Salivary Gland Cancer: An Update on Present and Emerging Therapies

• Date :
• 0    
  0

Salivary Gland Cancer: An Update on Present and Emerging Therapies 2

• Date :
• 0    
  0

Strategies to Overcome Clinical, Regulatory, and Financial Challenges in the Implementation of Personalized Medicine

• Date :
• 0    
  0

Strategies to Overcome Clinical, Regulatory, and Financial Challenges in the Implementation of Personalized Medicine 2

• Date :
• 0    
  0

Strategies to Overcome Clinical, Regulatory, and Financial Challenges in the Implementation of Personalized Medicine 3

• Date :
• 0    
  0

Surgical Management and Minimally Invasive Approaches for the Treatment of Metastatic Sarcoma

• Date :
• 0    
  0

Surgical Management and Minimally Invasive Approaches for the Treatment of Metastatic Sarcoma 2

• Date :
• 0    
  0

Surveillance Options for Patients with Uveal Melanoma Following Definitive Management

• Date :
• 0    
  0

Surveillance and Monitoring in Breast Cancer Survivors: Maximizing Benefit and Minimizing Harm

• Date :
• 0    
  0

Surveillance and Monitoring in Breast Cancer Survivors: Maximizing Benefit and Minimizing Harm 2

• Date :
• 0    
  0

Surveillance and Monitoring in Breast Cancer Survivors: Maximizing Benefit and Minimizing Harm 3

• Date :
• 0    
  0

Congrès ESMO 2026

• Date :
• 798    
  0

Congrès ESMO d'Immuno-Oncologie 2025

• Date :
• 1312    
  0

SABCS 2025 Symposium

• Date :
• 7706    
  0

Congrès ESMO Asie 2025

• Date :
• 948    
  0

17ᵉ Congrès Européen Multidisciplinaire sur le Cancer Urologique - EMUC25

• Date :
• 1409    
  0